Literature DB >> 28938972

Mitochondrial Metabolism: Yin and Yang for Tumor Progression.

Lorea Valcarcel-Jimenez1, Edoardo Gaude2, Veronica Torrano3, Christian Frezza4, Arkaitz Carracedo5.   

Abstract

Altered metabolism is a distinct feature of cancer cells. During transformation, the entire metabolic network is rewired to efficiently convert nutrients to biosynthetic precursors to sustain cancer cell growth and proliferation. Whilst the molecular underpinnings of this metabolic reprogramming have been described, its role in tumor progression is still under investigation. Importantly, the mitochondrion is a central actor in many of the metabolic processes that are altered in tumors. Yet, we have only begun to understand the dualities of mitochondrial function during cancer metastasis and therapy resistance. Paradoxically, mitochondrial metabolism can be both advantageous and detrimental to these processes, highlighting the need for a better understanding of the molecular and microenvironmental cues that define the role of this fascinating organelle. In this review article, we present an updated view on the different mitochondrial metabolic strategies adopted by cancer cells to overcome the many hurdles faced during tumor progression.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28938972      PMCID: PMC6047739          DOI: 10.1016/j.tem.2017.06.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  67 in total

1.  A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.

Authors:  Chi Luo; Ji-Hong Lim; Yoonjin Lee; Scott R Granter; Ajith Thomas; Francisca Vazquez; Hans R Widlund; Pere Puigserver
Journal:  Nature       Date:  2016-08-31       Impact factor: 49.962

Review 2.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis.

Authors:  Souvik Dey; Carly M Sayers; Ioannis I Verginadis; Stacey L Lehman; Yi Cheng; George J Cerniglia; Stephen W Tuttle; Michael D Feldman; Paul J L Zhang; Serge Y Fuchs; J Alan Diehl; Constantinos Koumenis
Journal:  J Clin Invest       Date:  2015-05-26       Impact factor: 14.808

4.  Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model.

Authors:  Xin Lu; Bryson Bennet; Euphemia Mu; Joshua Rabinowitz; Yibin Kang
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

Review 5.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

6.  MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

Authors:  Patricia Sancho; Emma Burgos-Ramos; Alejandra Tavera; Tony Bou Kheir; Petra Jagust; Matthieu Schoenhals; David Barneda; Katherine Sellers; Ramon Campos-Olivas; Osvaldo Graña; Catarina R Viera; Mariia Yuneva; Bruno Sainz; Christopher Heeschen
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

7.  Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival.

Authors:  Edoardo Gaude; Christian Frezza
Journal:  Nat Commun       Date:  2016-10-10       Impact factor: 14.919

8.  Quantitative flux analysis reveals folate-dependent NADPH production.

Authors:  Jing Fan; Jiangbin Ye; Jurre J Kamphorst; Tomer Shlomi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Nature       Date:  2014-05-04       Impact factor: 49.962

9.  Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities.

Authors:  Emma M Kerr; Edoardo Gaude; Frances K Turrell; Christian Frezza; Carla P Martins
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

10.  Altered glutamine metabolism in platinum resistant ovarian cancer.

Authors:  Chantelle D Hudson; Alyssa Savadelis; Anil Belur Nagaraj; Peronne Joseph; Stefanie Avril; Analisa DiFeo; Norbert Avril
Journal:  Oncotarget       Date:  2016-07-05
View more
  23 in total

Review 1.  Mitochondrial calcium uniporter complex modulation in cancerogenesis.

Authors:  Saverio Marchi; Veronica Angela Maria Vitto; Alberto Danese; Mariusz R Wieckowski; Carlotta Giorgi; Paolo Pinton
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

2.  The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine.

Authors:  Qing Yan
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

Review 4.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

Review 5.  The peroxisome: an update on mysteries 2.0.

Authors:  Markus Islinger; Alfred Voelkl; H Dariush Fahimi; Michael Schrader
Journal:  Histochem Cell Biol       Date:  2018-09-15       Impact factor: 4.304

6.  Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer.

Authors:  Lorea Valcarcel-Jimenez; Alice Macchia; Natalia Martín-Martín; Ana Rosa Cortazar; Ariane Schaub-Clerigué; Mikel Pujana-Vaquerizo; Sonia Fernández-Ruiz; Isabel Lacasa-Viscasillas; Aida Santos-Martin; Ana Loizaga-Iriarte; Miguel Unda-Urzaiz; Ivana Hermanova; Ianire Astobiza; Mariona Graupera; Julia Starkova; James Sutherland; Rosa Barrio; Ana M Aransay; Arkaitz Carracedo; Verónica Torrano
Journal:  Cell Death Dis       Date:  2018-10-11       Impact factor: 8.469

7.  Breath biopsy for early detection and precision medicine in cancer.

Authors:  Marc van der Schee; Hazel Pinheiro; Edoardo Gaude
Journal:  Ecancermedicalscience       Date:  2018-07-19

8.  Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC.

Authors:  Gro V Røsland; Sissel E Dyrstad; Deusdedit Tusubira; Reham Helwa; Tuan Zea Tan; Maria L Lotsberg; Ina K N Pettersen; Anna Berg; Charlotte Kindt; Fredrik Hoel; Kirstine Jacobsen; Ari J Arason; Agnete S T Engelsen; Henrik J Ditzel; Per E Lønning; Camilla Krakstad; Jean P Thiery; James B Lorens; Stian Knappskog; Karl J Tronstad
Journal:  Cancer Metab       Date:  2019-06-01

9.  Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors.

Authors:  Snehal Bindra; Marlon A McGill; Marina K Triplett; Anisha Tyagi; Premal H Thaker; Laila Dahmoush; Michael J Goodheart; R Todd Ogden; Edward Owusu-Ansah; Kalpita R Karan; Steve Cole; Anil K Sood; Susan K Lutgendorf; Martin Picard
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.996

10.  Chlorogenic Acid Ameliorates Damage Induced by Fluorene-9-Bisphenol in Porcine Sertoli Cells.

Authors:  Shaoxuan Zhang; Boxing Sun; Dali Wang; Ying Liu; Jing Li; Jiajia Qi; Yonghong Zhang; Chunyan Bai; Shuang Liang
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.